S&P 500   3,285.24 (+1.19%)
DOW   27,059.47 (+0.91%)
QQQ   270.54 (+1.94%)
AAPL   111.60 (+3.12%)
MSFT   207.58 (+2.16%)
FB   253.57 (+1.62%)
GOOGL   1,438.22 (+1.08%)
AMZN   3,079.66 (+1.98%)
TSLA   402.62 (+3.82%)
NVDA   511.70 (+3.60%)
BABA   269.20 (-0.20%)
CGC   14.08 (-1.33%)
GE   6.09 (+0.50%)
MU   48.72 (-1.52%)
AMD   77.82 (+2.64%)
T   27.92 (-0.43%)
F   6.51 (-2.25%)
ACB   4.98 (-4.23%)
GILD   62.24 (-0.02%)
NFLX   480.77 (+1.63%)
DIS   122.84 (+0.29%)
BAC   23.34 (+0.00%)
BA   151.48 (+3.72%)
S&P 500   3,285.24 (+1.19%)
DOW   27,059.47 (+0.91%)
QQQ   270.54 (+1.94%)
AAPL   111.60 (+3.12%)
MSFT   207.58 (+2.16%)
FB   253.57 (+1.62%)
GOOGL   1,438.22 (+1.08%)
AMZN   3,079.66 (+1.98%)
TSLA   402.62 (+3.82%)
NVDA   511.70 (+3.60%)
BABA   269.20 (-0.20%)
CGC   14.08 (-1.33%)
GE   6.09 (+0.50%)
MU   48.72 (-1.52%)
AMD   77.82 (+2.64%)
T   27.92 (-0.43%)
F   6.51 (-2.25%)
ACB   4.98 (-4.23%)
GILD   62.24 (-0.02%)
NFLX   480.77 (+1.63%)
DIS   122.84 (+0.29%)
BAC   23.34 (+0.00%)
BA   151.48 (+3.72%)
S&P 500   3,285.24 (+1.19%)
DOW   27,059.47 (+0.91%)
QQQ   270.54 (+1.94%)
AAPL   111.60 (+3.12%)
MSFT   207.58 (+2.16%)
FB   253.57 (+1.62%)
GOOGL   1,438.22 (+1.08%)
AMZN   3,079.66 (+1.98%)
TSLA   402.62 (+3.82%)
NVDA   511.70 (+3.60%)
BABA   269.20 (-0.20%)
CGC   14.08 (-1.33%)
GE   6.09 (+0.50%)
MU   48.72 (-1.52%)
AMD   77.82 (+2.64%)
T   27.92 (-0.43%)
F   6.51 (-2.25%)
ACB   4.98 (-4.23%)
GILD   62.24 (-0.02%)
NFLX   480.77 (+1.63%)
DIS   122.84 (+0.29%)
BAC   23.34 (+0.00%)
BA   151.48 (+3.72%)
S&P 500   3,285.24 (+1.19%)
DOW   27,059.47 (+0.91%)
QQQ   270.54 (+1.94%)
AAPL   111.60 (+3.12%)
MSFT   207.58 (+2.16%)
FB   253.57 (+1.62%)
GOOGL   1,438.22 (+1.08%)
AMZN   3,079.66 (+1.98%)
TSLA   402.62 (+3.82%)
NVDA   511.70 (+3.60%)
BABA   269.20 (-0.20%)
CGC   14.08 (-1.33%)
GE   6.09 (+0.50%)
MU   48.72 (-1.52%)
AMD   77.82 (+2.64%)
T   27.92 (-0.43%)
F   6.51 (-2.25%)
ACB   4.98 (-4.23%)
GILD   62.24 (-0.02%)
NFLX   480.77 (+1.63%)
DIS   122.84 (+0.29%)
BAC   23.34 (+0.00%)
BA   151.48 (+3.72%)
Log in
NASDAQ:AKCA

Akcea Therapeutics SEC Filings & 10K Form

$18.14
0.00 (0.00 %)
(As of 09/25/2020 02:07 PM ET)
Add
Compare
Today's Range
$18.13
Now: $18.14
$18.16
50-Day Range
$10.88
MA: $14.66
$18.28
52-Week Range
$8.00
Now: $18.14
$22.47
Volume95,929 shs
Average Volume352,730 shs
Market Capitalization$1.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.47

SEC Filings

Akcea Therapeutics (NASDAQ:AKCA) SEC Filings

DateFilerForm TypeView
09/24/2020
4:28 PM
Akcea Therapeutics (Subject)
Form SC 13E3/A
09/24/2020
4:26 PM
Akcea Therapeutics (Subject)
Form SC 14D9/A
09/24/2020
4:23 PM
Akcea Therapeutics (Subject)
IONIS PHARMACEUTICALS INC (Filed by)
Form SC TO-T/A
09/24/2020
3:25 PM
Akcea Therapeutics (Issuer)
Patterson Joshua F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
3:21 PM
Akcea Therapeutics (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2020
3:19 PM
Akcea Therapeutics (Issuer)
McDevitt Damien (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
4:10 PM
Akcea Therapeutics (Subject)
Form SC 14D9/A
09/14/2020
9:00 PM
Akcea Therapeutics (Subject)
Form SC 13E3
09/14/2020
4:24 PM
Akcea Therapeutics (Subject)
Form SC 14D9
09/14/2020
4:11 PM
Akcea Therapeutics (Subject)
IONIS PHARMACEUTICALS INC (Filed by)
Form SC TO-T
09/01/2020
4:15 PM
Akcea Therapeutics (Subject)
Form SC14D9C
09/01/2020
3:18 PM
Akcea Therapeutics (Subject)
IONIS PHARMACEUTICALS INC (Filed by)
Form SC TO-C
08/31/2020
4:28 PM
Akcea Therapeutics (Subject)
IONIS PHARMACEUTICALS INC (Filed by)
Form SC TO-C
08/31/2020
4:17 PM
Akcea Therapeutics (Subject)
Form SC14D9C
08/31/2020
4:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
6:12 AM
Akcea Therapeutics (Subject)
IONIS PHARMACEUTICALS INC (Filed by)
Form SC 13D/A
08/31/2020
6:07 AM
Akcea Therapeutics (Subject)
IONIS PHARMACEUTICALS INC (Filed by)
Form SC TO-C
08/04/2020
3:18 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2020
4:18 PM
Akcea Therapeutics (Issuer)
Patterson Joshua F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
4:31 PM
Akcea Therapeutics (Issuer)
Andrews William T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
4:27 PM
Akcea Therapeutics (Issuer)
Andrews William T. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2020
6:30 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
3:08 PM
Akcea Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/19/2020
4:41 PM
Akcea Therapeutics (Issuer)
PRICE MICHAEL DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
4:37 PM
Akcea Therapeutics (Issuer)
PRICE MICHAEL DENNIS (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/18/2020
6:30 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:00 PM
Akcea Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2020
3:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2020
4:30 PM
Akcea Therapeutics (Issuer)
Patterson Joshua F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2020
4:28 PM
Akcea Therapeutics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2020
4:24 PM
Akcea Therapeutics (Issuer)
Salzman Amber (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2020
4:16 PM
Akcea Therapeutics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2020
4:13 PM
Akcea Therapeutics (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2020
4:09 PM
Akcea Therapeutics (Issuer)
Yanni Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
6:00 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
7:41 PM
Akcea Therapeutics (Issuer)
McDevitt Damien (Reporting)
Form 4/A
03/24/2020
6:37 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
3:35 PM
Akcea Therapeutics (Issuer)
Howarth Alex G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:29 PM
Akcea Therapeutics (Issuer)
Patterson Joshua F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2020
3:22 PM
Akcea Therapeutics (Issuer)
McDevitt Damien (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
3:18 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
6:30 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
3:40 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
3:18 PM
Akcea Therapeutics (Filer)
Form DEF 14C
02/25/2020
3:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2020
3:44 PM
Akcea Therapeutics (Issuer)
Salzman Amber (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2020
6:30 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
3:31 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2020
6:30 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2020
5:05 PM
Akcea Therapeutics (Issuer)
O'Dea Louis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
5:03 PM
Akcea Therapeutics (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
6:00 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2020
4:23 PM
Akcea Therapeutics (Issuer)
O'Dea Louis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
4:21 PM
Akcea Therapeutics (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
3:32 PM
Akcea Therapeutics (Issuer)
IONIS PHARMACEUTICALS INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
6:00 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:35 PM
Akcea Therapeutics (Issuer)
Yanni Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:32 PM
Akcea Therapeutics (Issuer)
Yanni Barbara (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2019
3:15 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
3:08 PM
Akcea Therapeutics (Issuer)
Howarth Alex G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
6:30 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
1:39 PM
Akcea Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2019
3:21 PM
Akcea Therapeutics (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
3:17 PM
Akcea Therapeutics (Issuer)
Jenne Kyle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2019
6:30 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
3:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
8:26 PM
Akcea Therapeutics (Issuer)
Goldberg Jeff Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
4:52 PM
Akcea Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
6:22 PM
Akcea Therapeutics (Issuer)
O'Dea Louis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
4:24 PM
Akcea Therapeutics (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
4:22 PM
Akcea Therapeutics (Issuer)
McDevitt Damien (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
4:12 PM
Akcea Therapeutics (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
4:11 PM
Akcea Therapeutics (Issuer)
YANG MICHAEL J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/23/2019
3:35 PM
Akcea Therapeutics (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2019
3:33 PM
Akcea Therapeutics (Issuer)
KLEIN JOSEPH III (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/23/2019
6:15 AM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
2:24 PM
Akcea Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:52 PM
Akcea Therapeutics (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:31 PM
Akcea Therapeutics (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:28 PM
Akcea Therapeutics (Issuer)
Goldberg Jeff Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:46 PM
Akcea Therapeutics (Issuer)
MOSCICKI RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:42 PM
Akcea Therapeutics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:38 PM
Akcea Therapeutics (Issuer)
Hochberg Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:35 PM
Akcea Therapeutics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:31 PM
Akcea Therapeutics (Issuer)
FITZGERALD EDWARD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:28 PM
Akcea Therapeutics (Issuer)
GABRIELI CHRISTOPHER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
10:30 AM
Akcea Therapeutics (Filer)
Form CT ORDER
05/20/2019
3:23 PM
Akcea Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2019
4:24 PM
Akcea Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:16 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
7:43 AM
Akcea Therapeutics (Filer)
Form DEFA14C
04/29/2019
7:41 AM
Akcea Therapeutics (Filer)
Form DEF 14C
04/26/2019
3:29 PM
Akcea Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2019
6:00 PM
Akcea Therapeutics (Issuer)
Goldberg Jeff Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:59 PM
Akcea Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:33 PM
Akcea Therapeutics (Subject)
IONIS PHARMACEUTICALS INC (Filed by)
Form SC 13D/A
04/02/2019
3:20 PM
Akcea Therapeutics (Issuer)
IONIS PHARMACEUTICALS INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.